Low levels of testosterone may increase the long-term risk of death in men over 50 years old, according to researchers with the Department of Family and Preventive Medicine at the University of California, San Diego School of Medicine.
Findings from a Phase III study by the Eastern Cooperative Oncology Group (ECOG) were presented yesterday at the American Society of Clinical Oncology (ASCO) meeting in Chicago and demonstrate the impressive survival benefits of using Revlimid (lenalidomide) with reduced doses of the steroid dexamethasone.
AMA Vice President, Dr Choong-Siew Yong, warned consumers could be seriously misled by proposed new food labelling regulations.
Dublin company, Valentia Technologies, and Fermanagh company, McElwaine SMART Technologies have teamed up with the University?s Technologies for Rurality, Ageing and Independent Living (TRAIL) laboratory to develop new health care delivery systems that will help elderly people continue to live longer in their own homes.
US Governor Edward G. Rendell signed two executive orders to improve how Pennsylvanians with chronic disease receive health care in the future. Both initiatives are part of the Governor?s Prescription for Pennsylvania health care reform plan.
New data demonstrated that the combination asthma therapy, SYMBICORT? (budesonide/formoterol fumarate dihydrate), led to significant improvements in health-related quality of life (HRQL) and greater patient-reported satisfaction with asthma treatment, versus its monocomponents (budesonide or formoterol) or placebo.
Doctors should be seizing the opportunity to lead the fight against chronic illnesses like diabetes and heart disease, according to the next head of the international organization for GPs.
Researchers at the University at Buffalo and Roswell Park Cancer Institute have shown for the first time that an association exists between long-standing periodontitis, or gum disease, and risk of tongue cancer.
Treatment with the drug clodronate does not improve overall survival for men with localized prostate cancer or delay the disease?s progression to metastatic cancer, according to the results of a randomized clinical trial.
While regular multivitamin use is not linked with early or localized prostate cancer, taking too many multivitamins may be associated with an increased risk for advanced or fatal prostate cancers, according to a study in the May 16 issue of the Journal of the National Cancer Institute.